Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis.

Journal of neuroimmunology - 29 May 2009

Goris An, Dobosi Rita, Boonen Steven, Nagels Guy, Dubois Bénédicte

Abstract excerpt

Several lines of evidence implicate CD56(bright) NK cells in the pathogenesis of multiple sclerosis (MS). This proposed immunoregulatory pathway involves already established susceptibility genes such as interleukin-2 receptor alpha (IL2RA) and interleukin-7 receptor (IL7R). We therefore investigated the CD56(bright) NK cell effector molecule KIR2DL4 for its involvement in genetic susceptibility to MS in a study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Testing
Share to CD56 Antigen
Share to Cell Membrane

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Genetic Markers

Share to Killer Cells, Natural

Share to Multiple Sclerosis

Share to Predictive Value of Tests

Source

Identifiers

PMID: 19304328
DOI: 10.1016/j.jneuroim.2009.03.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis.PMID 19304328Read ↗

KIR2DL4 (CD158d) genotype influences expression and function in NK cells.Semantic proximity Read ↗

The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans.Semantic proximity Read ↗

KIRs and their HLA ligands in remitting-relapsing multiple sclerosis.Semantic proximity Read ↗

Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.Semantic proximity Read ↗

Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.Semantic proximity Read ↗

Killer immunoglobulin‐like receptor ligand HLA‐Bw4 protects against multiple sclerosisSemantic proximity Read ↗

Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility.Semantic proximity Read ↗

Killer cell immunoglobulin-like receptor (KIR) alleles suggested to be associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).Semantic proximity Read ↗

Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.Semantic proximity Read ↗

Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease.Semantic proximity Read ↗

Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.Semantic proximity Read ↗

Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.